These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7104178)

  • 21. ECT/chlorpromazine combination versus chlorpromazine alone in acutely schizophrenic patients.
    Janakiramaiah N; Channabasavanna SM; Murthy NS
    Acta Psychiatr Scand; 1982 Dec; 66(6):464-70. PubMed ID: 7180565
    [No Abstract]   [Full Text] [Related]  

  • 22. Stability of positive and negative symptom constructs during neuroleptic treatment in schizophrenia.
    Goldman RS; Tandon R; Liberzon I; Goodson J; Greden JF
    Psychopathology; 1991; 24(4):247-52. PubMed ID: 1754657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
    Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
    J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ataractic drugs versus ECT in schizophrenia.
    Spensley J
    Am J Psychiatry; 1973 Oct; 130(10):1162-3. PubMed ID: 4728918
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study.
    Kolakowska T; Orr M; Gelder M; Heggie M; Wiles D; Franklin M
    Br J Psychiatry; 1979 Oct; 135():352-9. PubMed ID: 519119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the relative efficacy of Serenace and chlorpromazine in the treatment of chronic schizophrenics.
    Rompel H; Segal H
    J Int Med Res; 1978; 6(2):126-32. PubMed ID: 344086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
    Meltzer HY; Busch DA; Creese IR; Snyder SH; Fang VS
    Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment.
    Wiles DH; Kolakowska T; McNeilly AS; Mandelbrote BM; Gelder MG
    Psychol Med; 1976 Aug; 6(3):407-15. PubMed ID: 996201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does a plasma level of chlorpromazine help?
    Van Putten T; May PR; Jenden DJ
    Psychol Med; 1981 Nov; 11(4):729-34. PubMed ID: 6119719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine.
    Lieberman JA; Phillips M; Gu H; Stroup S; Zhang P; Kong L; Ji Z; Koch G; Hamer RM
    Neuropsychopharmacology; 2003 May; 28(5):995-1003. PubMed ID: 12700715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses.
    Wode-Helgodt B; Alfredsson G
    Psychopharmacology (Berl); 1981; 73(1):55-62. PubMed ID: 6785790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How long does chlorpromazine last?
    Lacoursiere RB; Spohn HE
    J Nerv Ment Dis; 1976 Oct; 163(4):267-75. PubMed ID: 972329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients.
    Kolakowska T; Wiles DH; McNeilly AS; Gelder MG
    Psychol Med; 1975 May; 5(2):214-6. PubMed ID: 240179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment.
    Nagaoka S; Iwamoto N; Arai H
    Biol Psychiatry; 1997 Apr; 41(8):857-64. PubMed ID: 9099412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison between electro-acupuncture with chlorpromazine and chlorpromazine alone in 60 schizophrenic patients].
    Zhuge DY; Chen JK
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Jul; 13(7):408-9, 388. PubMed ID: 8251722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical relevance of an auditory attention task (PAT) in a longitudinal study of chronic schizophrenia, with placebo substitution for chlorpromazine.
    Pigache RM
    Schizophr Res; 1993 Jun; 10(1):39-50. PubMed ID: 8369231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of chlorpromazine and key metabolites.
    Yeung PK; Hubbard JW; Korchinski ED; Midha KK
    Eur J Clin Pharmacol; 1993; 45(6):563-9. PubMed ID: 8157044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients.
    Wu S; Xing Q; Gao R; Li X; Gu N; Feng G; He L
    Neurosci Lett; 2005 Mar; 376(1):1-4. PubMed ID: 15694263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of a side effect as a qualitative indicator of plasma chlorpromazine levels.
    Chetty M; Gouws E; Miller R; Moodley SV
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):77-82. PubMed ID: 10082231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.